Rasagiline improves polysomnographic sleep parameters in patients with Parkinson's disease: a double-blind, baseline-controlled trial.

Wiebke HermannM FauserM WieneckeS BrownA MaaßC OssigK OttoM D BrandtM LöhleU SchwanebeckX GraehlertH ReichmannAlexander Storch

Published in: European journal of neurology (2018)

In patients with PD with sleep disturbances, rasagiline showed beneficial effects on sleep quality as measured by polysomnography. These effects were probably not related to motor improvement or translated into improved overall sleep quality perception by patients.

Keyphrases

sleep quality
depressive symptoms
physical activity
end stage renal disease
ejection fraction
newly diagnosed
obstructive sleep apnea
prognostic factors
clinical trial
randomized controlled trial
drug induced